NFKB1 and lip and oral cavity carcinoma: Exhibits dose- and time-dependent antiproliferative and pro-apoptotic effects through mitochondria/death receptor, MAPK, NF-κB, and HIF-1α signaling pathways; potential candidate for oral cancer chemotherapy [234].